Concepedia

Jinyu Yuan

JY

Statistics

Publications

16

Citations

1.8K

H-Index

14

Active since

2006

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Seoul National University Hospital

United States Military Academy

KU Leuven

Jinyu Yuan is an author at Pfizer (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

2006–2024

16

Publications

16

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

Martin Gore, Cezary Szczylik, Camillo Porta et al. · The Lancet Oncology · 2009 · 591 citations

Medicine, Oncology, Pharmacology +13

Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Mark R. Olsen et al. · Journal of Clinical Oncology · 2012 · 275 citations · Full text

Medicine, Oncology, Pharmacology +17

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +14

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer

Hope S. Rugo, Abhijit Barve, Cornelius F. Waller et al. · JAMA · 2016 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

Martin Gore, Camillo Porta, Sergio Bracarda et al. · Cancer · 2010 · 142 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 16